Tolerability and durable respones of the PI3K delta inhibitor ME-401 administered on an intermittent schedule in relapsed/refractory (R/R) follicular lymphoma (FL) and other B-cell malignancies Meeting Abstract


Authors: Zelenetz, A. D.; Reddy, N.; Jagadeesh, D.; Stathis, A.; Salman, H. S.; Soumerai, J. D.; Kenkre, V. P.; Asch, A. S.; Llorin-Sangalang, J.; Li, J.; Gorbatchevsky, I.; Pagel, J. M.
Abstract Title: Tolerability and durable respones of the PI3K delta inhibitor ME-401 administered on an intermittent schedule in relapsed/refractory (R/R) follicular lymphoma (FL) and other B-cell malignancies
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual Conference
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368303237
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.8016
Notes: Meeting Abstract: 8016 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz